Real-World Deutetrabenazine Dosing Patterns in Patients With Huntington's Disease or Tardive Dyskinesia

被引：0
|
作者：
Ayyagari, R. [1 ]
Wilhelm, A. [1 ]
Alexander, J. [1 ]
Chaijale, N. [1 ]
Garcia-Horton, V. [1 ]
Devine, F. [1 ]
Carroll, B. [1 ]
机构：
[1] Anal Grp Inc, Boston, MA USA
来源：
MOVEMENT DISORDERS | 2020年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
76
引用
收藏
页码：S31 / S31
页数：1
相关论文
共 50 条
  • [31] VOLUNTARY MOVEMENT DYSFUNCTION IN HUNTINGTON DISEASE AND TARDIVE-DYSKINESIA
    DAVID, AS
    JESTE, DV
    FOLSTEIN, MF
    FOLSTEIN, SE
    ACTA NEUROLOGICA SCANDINAVICA, 1987, 75 (02): : 130 - 139
  • [32] Long-term Safety and Efficacy of Deutetrabenazine in Younger and Older Patients With Tardive Dyskinesia
    Sajatovic, M.
    Wilhelm, A.
    Finkbeiner, S.
    Barkay, H.
    Chaijale, N.
    Gross, N.
    Gordon, M.
    MOVEMENT DISORDERS, 2020, 35 : S34 - S34
  • [33] Long-Term Safety and Efficacy of Deutetrabenazine in Younger and Older Patients With Tardive Dyskinesia
    Sajatovic, Martha
    Finkbeiner, Stacy
    Wilhelm, Amanda
    Barkay, Hadas
    Chaijale, Nayla
    Gross, Nicholas
    Gordon, Mark Forrest
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2022, 30 (03): : 360 - 371
  • [34] Long-term Safety and Efficacy of Deutetrabenazine in Younger and Older Patients With Tardive Dyskinesia
    Sajatovic, Martha
    Wilhelm, Amanda
    Finkbeiner, Stacy
    Barkay, Hadas
    Chaijale, Nayla
    Gross, Nicholas
    Gordon, Mark Forrest
    NEUROLOGY, 2020, 94 (15)
  • [35] Real-World Evaluation of Patient Characteristics and Disease Management in Long-Term Valbenazine Treatment in Adults with Tardive Dyskinesia
    Goldberg, E.
    Yonan, C.
    Longo, N.
    Cratty, H.
    Nicosia, M.
    Sampalis, J.
    Carmack, T.
    Siegert, S.
    Angelov, A.
    MOVEMENT DISORDERS, 2020, 35 : S39 - S39
  • [36] REAL-WORLD EVALUATION OF PATIENT CHARACTERISTICS AND DISEASE MANAGEMENT IN LONG-TERM VALBENAZINE TREATMENT IN ADULTS WITH TARDIVE DYSKINESIA
    Siegert, S.
    Yonan, C.
    Longo, N.
    Cratty, H.
    Nicosia, M.
    Sampalis, J.
    Carmack, T.
    Dhanda, R.
    Farahmand, K.
    Lundt, L.
    Angelov, A.
    Goldberg, E.
    PARKINSONISM & RELATED DISORDERS, 2020, 79 : E117 - E118
  • [37] Antifibrotic Dosing Patterns in Patients With Idiopathic Pulmonary Fibrosis in Real-World Data Sources
    Swaminathan, A. C.
    Stevens, S. R.
    Guidot, D. M.
    Elpers, B.
    Chopra, P.
    Palmer, S. M.
    Wruck, L. M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [38] Patterns of topiramate utilization among Medicaid patients: Diagnosis, comorbidities and real-world dosing
    Poston, S
    Rupnow, M
    Dickson, M
    Johnsrud, M
    Gdovin, JM
    Bramley, T
    Armstrong, RB
    VALUE IN HEALTH, 2006, 9 (03) : A86 - A86
  • [39] Real-world study of direct oral anticoagulant dosing patterns in patients with atrial fibrillation
    Gustafson, Whitney L.
    Saunders, John
    Vazquez, Sara R.
    Jones, Aubrey E.
    Witt, Daniel M.
    PHARMACY PRACTICE-GRANADA, 2019, 17 (04):
  • [40] Treatment Patterns in a Real-World Sample of Patients with Parkinson's Disease and Motor Fluctuations
    Hauser, Robert A.
    Sethi, Kapil
    Klepitskaya, Olga
    Odak, Shardul
    Macahilig, Cynthia
    Joshi, Namita
    Ng, Xinyi
    Olson, Kurt
    Liang, Grace S.
    Yonan, Chuck
    Serbin, Michael
    NEUROLOGY, 2021, 96 (15)
12345